Published in Clin Exp Immunol on June 01, 1983
The influence of cyclosporin A on cell-mediated immunity. Clin Exp Immunol (1988) 1.05
Cyclosporin A prevents suppression of delayed-type hypersensitivity in mice immunized with high-dose sheep erythrocytes. Immunology (1987) 0.97
Effect of cyclosporin A on the T-effector and T-suppressor cell response in contact sensitivity. Immunology (1986) 0.90
Topical cyclosporin A in nickel contact hypersensitivity: results of a preliminary clinical and immunohistochemical investigation. Clin Exp Immunol (1986) 0.84
T-cell-independent macrophage activation in mice induced with rRNA from Listeria monocytogenes and dimethyldioctadecylammonium bromide. Infect Immun (1986) 0.80
Antigen presentation and HLA-DR expression by FK-506-treated human monocytes. Immunology (1990) 0.79
Effect of cyclosporin A on autoimmune tubulointerstitial nephritis in the brown Norway rat. Clin Exp Immunol (1987) 0.78
Renal and hepatic function in rats treated with cyclosporin A in combination with gentamicin or cephalosporin antibiotics. Br J Exp Pathol (1983) 0.75
Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology (1977) 7.10
A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods (1980) 6.44
Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10
Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol (1981) 4.31
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92
Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment. Lancet (1978) 2.80
Role of the clotting system in cell-mediated hypersensitivity. I. Fibrin deposition in delayed skin reactions in man. J Exp Med (1973) 2.75
Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67
Studies on the immunosuppressive properties of cyclosporin a in rats receiving renal allografts. Transplantation (1980) 2.21
Use of cyclosporin A in allogeneic bone marrow transplantation in the rat. Nature (1979) 1.90
Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells. Transplantation (1979) 1.73
Cyclosporin A blocks receptors for HLA-DR antigens on T cells. Nature (1981) 1.61
Inhibition of T-cell activity by cyclosporin A. Scand J Immunol (1981) 1.61
Activity of the mononuclear phagocyte system in cyclosporin A-treated mice. Transplantation (1980) 1.54
Cyclosporin A--usefulness, risks and mechanism of action. Immunol Rev (1982) 1.50
Leukocyte procoagulant activity in man: an in vitro correlate of delayed-type hypersensitivity. J Immunol (1982) 1.49
Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats. J Clin Invest (1981) 1.40
A mechanism of migration inhibition in delayed-type hypersensitivity reactions. I. Fibrin deposition on the surface of elicited peritoneal macrophages on vivo. J Immunol (1981) 1.38
Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages. Immunology (1978) 1.37
The effects of anticoagulants and other drugs on cellular and cutaneous reactions to antigen in guinea-pigs with delayed-type hypersensitivity. Immunology (1965) 1.36
Selective effects of cyclosporin A on colony-forming lymphoid and myeloid cells in man. Nature (1979) 1.20
Cyclosporin A: in vivo and in vitro suppression of rat T-lymphocyte function. Immunology (1979) 1.16
The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat. Clin Exp Immunol (1982) 1.08
Effects of in vivo treatments with cyclosporin-A on mouse cell-mediated immune responses. Int J Immunopharmacol (1981) 1.08
Timing of cyclosporin-A therapy for abrogation of HVG and GVH responses in rats. Lancet (1979) 1.07
Nature of the unresponsiveness induced by cyclosporin A in rats bearing renal allografts. Transplantation (1979) 0.99
Soluble antigen from sheep erythrocytes: preparation and antigenic properties. Immunology (1970) 0.97
Effect of cyclosporin A on in vitro proliferative activity and immunoglobulin synthesis of isolated human lymphoid cell subpopulations. Clin Exp Immunol (1981) 0.91
Prolongation of segmental pancreatic allografts in dogs receiving cyclosporin A. Transplantation (1982) 0.89
Inhibition of cytokine production by a tumor cell product. Immunology (1982) 0.88
Prolongation of kidney survival during and after cyclosporin A therapy. Transplantation (1979) 0.88
Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29
The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81
FK 506: an immunosuppressant for the 1990s? Lancet (1991) 2.80
Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol (1999) 2.48
Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med (1994) 2.48
FK-506--how much potential? Immunol Today (1989) 2.20
Studies on cytophilic antibodies. 1. The production by mice of macrophage cytophilic antibodies to sheep erythrocytes: relationship to the production of other antibodies and the development of delayed-type hypersensitivity. Aust J Exp Biol Med Sci (1967) 2.05
Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines. Immunology (1983) 1.99
Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat Immunol (2001) 1.95
Production by stimulated macrophages of factors depressing lymphocyte transformation. Nature (1973) 1.92
Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med (1995) 1.88
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation (1996) 1.86
Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol (1997) 1.81
Macrophage cytophilic antibodies and delayed hypersensitivity. Br Med Bull (1967) 1.66
Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation. With oarticular reference to the liver. Transplantation (1996) 1.65
Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation (1995) 1.63
Transcytosis-associated protein (TAP)/p115 is a general fusion factor required for binding of vesicles to acceptor membranes. Proc Natl Acad Sci U S A (1995) 1.62
Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. J Virol (2000) 1.60
The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56
Phytohaemagglutinin-induced lymphocyte transformation in leprosy. Clin Exp Immunol (1971) 1.54
Use of propofol sedation in a pediatric emergency department: a prospective study. Clin Pediatr (Phila) (2001) 1.53
Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J Immunol (1996) 1.53
Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation (1995) 1.51
Specificity of cell-mediated cytotoxicity against human melanoma lines: evidence for "non-specific" killing by activated T-cells. Int J Cancer (1975) 1.48
Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood (2001) 1.47
Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo. J Immunol (2000) 1.47
Pregnancy specific beta1-glycoprotein--a product of the syncytiotrophoblast. Experientia (1976) 1.46
Immune reactions in human filariasis. J Clin Microbiol (1978) 1.43
Pathological changes developing in the rat during a 3-week course of high dosage cyclosporin A and their reversal following drug withdrawal. Transplantation (1981) 1.38
Toxicity of the immune suppressant cyclosporin A in the rat. J Pathol (1982) 1.38
Immunity to infection, allograft immunity and tumour immunity: parallels and contrasts. Transplant Rev (1974) 1.37
Mouse mast cells as anti-tumor effector cells. Cell Immunol (1980) 1.37
Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages. Immunology (1978) 1.37
The effects of anticoagulants and other drugs on cellular and cutaneous reactions to antigen in guinea-pigs with delayed-type hypersensitivity. Immunology (1965) 1.36
Seizure disorders in autism. J Am Acad Child Adolesc Psychiatry (1990) 1.36
Immunobiology of cyclosporin A--a review. Aust J Exp Biol Med Sci (1983) 1.31
Consensus document: therapeutic monitoring of tacrolimus (FK-506). Ther Drug Monit (1995) 1.30
Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients. Transplant Proc (1994) 1.29
Studies on cytophilic antibodies. IV. The effects of proteolytic enzymes (trypsin and papain) on the attachment to macrophages of cytophilic antibodies. Aust J Exp Biol Med Sci (1968) 1.28
Macrophage heterogeneity. Vox Sang (1979) 1.28
Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea-pigs. Immunology (1983) 1.27
Studies on cytophilic antibodies. V. Alloantibodies cytophilic for mouse macrophages. Aust J Exp Biol Med Sci (1969) 1.25
Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol (1994) 1.25
Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am J Transplant (2006) 1.24
Fundamental Ca2+ signaling mechanisms in mouse dendritic cells: CRAC is the major Ca2+ entry pathway. J Immunol (2001) 1.23
Concomitant immunity to syngeneic methylcholanthrene-induced tumours in mice. Occurrence and specificity of concomitant immunity. Aust J Exp Biol Med Sci (1973) 1.23
Serum-dependent adhesion and cytotoxicity of cells to Litomosoides carinii microfilariae. Nature (1976) 1.23
Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow. Transplantation (1998) 1.22
Effect of normal mouse serum on mouse lymphocyte transformation in vitro. Eur J Immunol (1974) 1.22
Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates. Am J Transplant (2013) 1.22
Cyclosporin: use outside transplantation. BMJ (1991) 1.22
Binding relationships of membrane tethering components. The giantin N terminus and the GM130 N terminus compete for binding to the p115 C terminus. J Biol Chem (2000) 1.21
Designer dendritic cells for tolerance induction: guided not misguided missiles. Trends Immunol (2001) 1.21
Evaluation of carrageenan as an immunosuppressive agent and mediator of intravascular coagulation. Biomedicine (1976) 1.20
Molecular cloning, characterization, and dynamics of rat formiminotransferase cyclodeaminase, a Golgi-associated 58-kDa protein. J Biol Chem (1998) 1.19
Dendritic cells and immune regulation in the liver. Gut (2003) 1.19
Biological and clinical significance of pregnancy-associated alpha2-glycorprotein (alpha/-PAG)-a review. Invest Cell Pathol (1981) 1.18
Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells. Int J Cancer (1975) 1.18
Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation (1997) 1.17
Generation of DC from mouse spleen cell cultures in response to GM-CSF: immunophenotypic and functional analyses. Immunology (1995) 1.17
Delivery of rapamycin to dendritic cells using degradable microparticles. J Control Release (2008) 1.17
Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol (1997) 1.16
Isolation, phenotype, and allostimulatory activity of mouse liver dendritic cells. Transplantation (1994) 1.16
Passive sensitization of tissue cells. 1. Passive sensitization of macrophages by guinea-pig cytophilic antibody. Int Arch Allergy Appl Immunol (1965) 1.15
Cyclosporine: immunology, toxicity and pharmacology in experimental animals. Agents Actions (1984) 1.14
New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25+CD4+ regulatory T cells. Am J Transplant (2008) 1.14
Mast cell granules cause proliferation of human microvascular endothelial cells. Lab Invest (1986) 1.14
Depressive effect of serum from patients with leprosy on mixed lymphocyte reactions. Influence of anti-leprosy treatment. Clin Exp Immunol (1975) 1.13
Experimental cyclosporin A nephrotoxicity. Br J Exp Pathol (1982) 1.12
Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal. Clin Exp Immunol (1990) 1.11
Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol Ther (2000) 1.10
Cyclosporine-induced fetotoxicity in the rat. Transplantation (1985) 1.10
Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function. Transplantation (1995) 1.10
Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation. Am J Transplant (2008) 1.10
Interleukin-17 antagonism inhibits acute but not chronic vascular rejection. Transplantation (2001) 1.09
Studies on cytophilic antibodies. II. The production by guinea-pigs of macrophage cytophilic antibodies to sheep erythrocytes and human serum albumin: relationship to the production of other antibodies and the development of delayed-type hypersensitivity. Aust J Exp Biol Med Sci (1968) 1.09
FK 506 inhibition of cyclosporine metabolism by human liver microsomes. Transplant Proc (1991) 1.09
Humoral factors influencing lymphocyte transformation. Prog Allergy (1976) 1.09
Toxicity of various carrageenans in the mouse. Br J Exp Pathol (1976) 1.09
Major histocompatibility complex class II antigen (HLA-DR, DQ and DP) expression in human fetal skin. Tissue Antigens (1986) 1.09
Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J Immunol (2001) 1.08
Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy. J Immunol (1998) 1.07
Effect of carrageenan on activity of the mononuclear phagocyte system in the mouse. Br J Exp Pathol (1978) 1.07
Adhesion molecule expression in psoriatic skin lesions and the influence of cyclosporin A. Clin Exp Immunol (1991) 1.07
Phenotypic and functional characterization of mouse hepatic CD8 alpha+ lymphoid-related dendritic cells. J Immunol (2000) 1.07
Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity. J Immunol (1997) 1.05
Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor kappa B. Transplantation (1999) 1.05
Interleukin-1 secretion by peripheral blood monocytes and synovial macrophages from patients with rheumatoid arthritis. J Rheumatol (1987) 1.04
Macrophage procoagulant activity as a measure of cell-mediated immunity in the mouse. J Immunol (1983) 1.04
Serum cyclosporin levels, hepatic drug metabolism and renal tubulotoxicity. Biochem Pharmacol (1984) 1.03
The influence of FK-506 on the thymus: an immunophenotypic and structural analysis. Immunology (1990) 1.03
FK-506 enters the clinic. Immunol Today (1990) 1.03
Immunological induction of DNA synthesis in mouse peritoneal macrophages. An expression of cell-mediated-immunity. Int Arch Allergy Appl Immunol (1973) 1.02
Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation (1998) 1.01
Cancer and subversion of host defences. Aust J Exp Biol Med Sci (1981) 1.00
IgA synthesis by peripheral blood mononuclear cells from normal and selectively IgA deficient subjects. Clin Exp Immunol (1979) 1.00